Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Pahwa, S; Muresan, P; Sleasman, J; Fenton, T; Moye, J; Deveikis, A; Wara, D; Van Dyke, R; Pediatric Aids Clinical Trials Study 402 team,

Published Date

  • June 2007

Published In

Volume / Issue

  • 119 / 6

Start / End Page

  • 1538 - 1541

PubMed ID

  • 17418382

Pubmed Central ID

  • 17418382

International Standard Serial Number (ISSN)

  • 0091-6749

Digital Object Identifier (DOI)

  • 10.1016/j.jaci.2006.12.674

Language

  • eng

Conference Location

  • United States